 Interview to Marco A. Pierotti
Fondazione Irccs
Istituto nazionale dei tumori
Scientific Director
Q: What kind of new stimulus is now strategic for your research on cancer?
A: Cancer is a disease generated by alterations of the genes in our cells. It is therefore very likely that the knowledge of the structure of our genome and the beginning of our understanding of its function will provide a significant advance in our knowledge and management of cancer. In this context our interest, internationally recognized, has been developed along two main lines of investigations which are predicted to bring a significant impact on cancer-related clinical aspects: a molecular classification of cancer based on molecular abnormalities and investigations in the field of inherited tumors.
|
|
Read more...
|
|
